Please login to the form below

Not currently logged in

Sandoz expands into Japan with €400m Aspen deal

Sandoz Novartis

Will gain presence in third largest generics market in the world

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

BiogenWill pay $100m upfont and pledges $210m in milestone payments

Takeda divests over-the-counter and prescription drugs to Stada for $660m

TakedaJapanese pharma said it has plans to divest $10bn in non-core assests

AstraZeneca launches $1bn Chinese investment fund

AstraZeneca AZAZ is among the top investors in the country with a strong market presence

Sanofi settles Lemtrada dispute with Genzyme investors for $315m

genzyme officesThe MS drug has been in decline amid increased market competition

Amgen buys BeiGene stake for $2.7bn to aid push into China

China flag thumbChina's oncology market forecast to nearly double in size by 2026

Novo bolstered by new diabetes, obesity products

Danish drug-maker has now raised its full-year sales forecast

BMS’ Opdivo stalls in Q3, but overall figures still top expectations

Bristol Myers Squibb logoGroup sales rose 6% to $6bn in the third quarter

GSK boosts outlook thanks to strong respiratory and vaccine sales

GSK - logo on buildingKey Q3 drivers include Shingrix vaccine and asthma drug Nucala

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts


Add my company

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...